Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 10

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 8
Chunk 10
---
 of $66,000,
as consideration for services rendered related to media and investor relations activities, strategic communications support, enhancement
to the Company’s market visibility and shareholder engagement. The fair value of the shares issued was determined based on the
market price of the Company’s Common Stock at the date of issuance and is included general and administrative expenses in the accompanying
2024 condensed consolidated statement of operations.

See
Note 6 – Stockholders’ Equity – Restricted Stock Units for additional details regarding the issuance and reversal
of Common Stock related to the vested restricted stock units.

See
Note 6 – Stockholders’ Equity – Warrants for additional details regarding the issuance of Common Stock upon
amendment and exercising of warrants.

Service
Agreement

On June 3, 2024, The Company entered into service agreements with three separate entities, each with a 36-month term. In connection therewith
the Company issued an aggregate of 3,487,500 restricted shares of Common Stock, 1,162,500 ratably to each entity with an aggregate fair
value at issuance totaling $4,638,375 which were registered upon the closing of the IPO in December 2024. In addition, each of the entities
agreed to and ultimately purchased 37,500 shares of the Company’s Common Stock at a purchase price of $1.33 per share prior to
the effective date of the IPO, resulting in aggregate proceeds of $150,000.

Pursuant
to the agreements, the counterparties are obligated to perform certain services, as defined, and the Company is recognizing the fair
value of the issued restricted shares as compensation expense over the 36-month term, the requisite service period. During the three
and nine months ended September 30, 2025 the Company recorded compensation expense of $389,707 and $1,156,410, respectively, related
to the agreement, which in general and administrative expenses in the accompanying condensed consolidated statements of operations. There
was no such expense recorded during the nine months ended September 30, 2024 due to the timing of the execution of the service agreements.

    16

JUPITER
NEUROSCIENCES, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note
6 – Stockholders’ Equity, continued

Stock
Options

The
Company grants stock under the provisions of its 2021 Equity Incentive Plan (“the Plan”).

On January 24,